Comprehensive evaluation of carboxylesterase-2 expression in normal human tissues using tissue array analysis

Applied Immunohistochemistry and Molecular Morphology

Volumn 10, Issue 4, 2002, Pages 374-380

  Zhang, Wanghai ^a   Xu, Guang ^a   McLeod, Howard L ^a,b  

^a MO   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carboxylesterase 2; Human normal tissues; Immunohistochemistry; Tissue array

Indexed keywords

CARBOXYLESTERASE; CARBOXYLESTERASE 2; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; ENZYME ANALYSIS; ENZYME LOCALIZATION; GASTROINTESTINAL TRACT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; KIDNEY PROXIMAL TUBULE; LIVER; LIVER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANTIBODIES; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PREGNANCY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TISSUE DISTRIBUTION;

EID: 0036901063     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200212000-00015     Document Type: Article

References (28)

1. Satoh T, Hosokawa M. The mammalian carboxylesterases: From molecules to functions. Annu Rev Pharmacol Toxicol 1998;38: 257-88.
2. Yamada T, Hosokawa M, Satoh T, et al. Immunohistochemistry with an antibody to human liver carboxylesterase in human brain tissues. Brain Res 1994;658:163-7.
3. Munger JS, Shi GP, Mark EA, et al. A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. J Biol Chem 1991;266:18832-8.
4. Hojring N, Svensmark O. Carboxylesterases with different substrate specificity in human brain extracts. J Neurochem 1976;27: 523-8.
5. Yan B, Matoney L, Yang D. Human carboxylesterases in term placentae: Enzymatic characterization, molecular cloning and evidence for the existence of multiple forms. Placenta 1999;20:599-607.
6. Humerickhouse R, Lohrbach K, Li L, et al. Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2. Cancer Res 2000;60:1189-92.
7. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000; 343:905-14.
8. Guichard S, Terret C, Hennebelle I, et al. CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissues. Br J Cancer 1999;80:364-70.
9. Kunimoto T, Nitta K, Tanaka T, et al. Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors. Cancer Res 1987;47:5944-7.
10. Kroetz DL, McBride OW, Gonzalez FJ. Glycosylation-dependent activity of baculovirus-expressed human liver carboxylesterases: cDNA cloning and characterization of two highly similar enzyme forms. Biochemistry 1993;32:11606-17.
11. Pindel EV, Kedishvili NY, Abraham TL, et al. Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. J Biol Chem 1997;272:14769-75.
12. Muskhelishvili L, Thompson PA, Kusewitt DF, et al. In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues. J Histochem Cytochem 2001;49:229-36.
13. Tsujita T, Miyata T, Okuda H. Purification of rat kidney carboxylesterase and its comparison with other tissue esterases. J Biochem 1988;103:327-31.
14. Morgan EW, Yan B, Greenway D, et al. Regulation of two rat liver microsomal carboxylesterase isozymes: Species differences, tissue distribution, and the effects of age, sex, and xenobiotic treatment of rats. Arch Biochem Biophys 1994;315:513-26.
15. McCracken NW, Blain PG, Williams FM. Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. Biochem Pharmacol 1993;45:31-6.
16. Dean RA, Zhang J, Brzezinski MR, et al. Tissue distribution of cocaine methyl esterase and ethyl transferase activities: Correlation with carboxylesterase protein. J Pharmacol Exp Ther 1995;275: 965-71.
17. Nambu K, Miyazaki H, Nakanishi Y, et al. Enzymatic hydrolysis of haloperidol decanoate and its inhibition by proteins. Biochem Pharmacol 1987;36:1715-22.
18. Gaustad R, Sletten K, Lovhaug D, et al. Purification and characterization of carboxylesterases from rat lung. Biochem J 1991;274: 693-7.
19. Tsujita T, Okuda H. Fatty acid ethyl ester synthase in rat adipose tissue and its relationship to carboxylesterase. J Biol Chem 1992; 267:23489-94.
20. Yan B, Yang D, Brady M, et al. Rat testicular carboxylesterase: Cloning, cellular localization, and relationship to liver hydrolase A. Arch Biochem Biophys 1995;316:899-908.
21. Nikula KJ, Novak RF, Chang IY, et al. Induction of nasal carboxylesterase in F344 rats following inhalation exposure to pyridine. Drug Metab Dispos 1995;23:529-35.
22. Yamada T, Kawaguchi N, Hosokawa M, et al. Localization of an isoform of carboxylesterase in rat brain differs from that in human brain. Brain Res 1995;674:175-9.
23. Inoue M, Morikawa M, Tsuboi M, et al. Comparative study of human intestinal and hepatic esterases as related to enzymatic properties and hydrolizing activity for ester-type drugs. Jpn J Pharamacol 1980;30:529-35.
24. Lund-Pero M, Jeppson B, Arneklo-Nobin B, et al. Non-specific steroidal esterase activity and distribution in human and other mammalian tissues. Clin Chim Acta 1994;224:9-20.
25. Zschunke F, Salmassi A. Kreipe H, et al. Heterogenous expression and putative structure of human monocyte/macrophage serine esterase 1. Res Immunol 1992;143:125-8.
26. Terasaki T, Takakuwa S, Moritani S, et al. Transport of monocarboxylic acids at the blood brain barrier, studies with monolayers of primary cultured bovine brain capillary endothelial cells. J Pharmacol Exp Ther 1991;258:932-7.
27. Gupta E, Lestingi TM, Mick R, et al. Metabolic fate of irinotecan in humans: Correlation of glucuronidation with diarrhea. Cancer Res 1994;54:3723-5.
28. Ahmed F, Vyas V, Cornfield A, et al. In vitro activation of irinotecan to SN-38 by human liver and intestine. Anticancer Res 1999; 19:2067-71.